Donepezil inhibits acetylcholinesterase in Alzheimer's disease by preventing the hydrolysis of acetylcholine, thereby reducing the risk of cholinergic neuronal dysfunction [6]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.